• Something wrong with this record ?

Aberrant tolerogenic functions and proinflammatory skew of dendritic cells in STAT1 gain-of-function patients may contribute to autoimmunity and fungal susceptibility

Z. Parackova, I. Zentsova, P. Vrabcova, A. Sediva, M. Bloomfield

. 2023 ; 246 (-) : 109174. [pub] 20221111

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

STAT1 gain-of-function (GOF) mutations underlie an inborn error of immunity hallmarked by chronic mucocutaneous candidiasis (CMC). Beyond the fungal susceptibility, attributed to Th17 failure, over half of the reported patients suffer from autoimmune manifestations, mechanism of which has not been explained yet. We hypothesized that the STAT1 mutations would affect dendritic cells' (DCs) properties and alter their inflammatory and tolerogenic functions. To test the hypothesis, we generated monocyte-derived DCs (moDCs) and tolerogenic DCs (tDCs). Functional and signaling studies, co-culture experiments and RNA sequencing demonstrated that STAT1 GOF DCs were profoundly altered in their phenotype and functions, characterized by loss of tolerogenic functions, proinflammatory skew and decreased capacity to induce Th17. Cytokine signaling, autophagy and metabolic processes were identified as the most prominently altered cellular processes. The results suggest that DCs are directly involved in STAT1 GOF-associated immune pathology, possibly contributing to both autoimmune manifestations and the failure of antifungal defense.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004775
003      
CZ-PrNML
005      
20230425171719.0
007      
ta
008      
230418s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.clim.2022.109174 $2 doi
035    __
$a (PubMed)36372319
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Parackova, Zuzana $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, Prague, Czech Republic. Electronic address: zuzana.parackova@fnmotol.cz
245    10
$a Aberrant tolerogenic functions and proinflammatory skew of dendritic cells in STAT1 gain-of-function patients may contribute to autoimmunity and fungal susceptibility / $c Z. Parackova, I. Zentsova, P. Vrabcova, A. Sediva, M. Bloomfield
520    9_
$a STAT1 gain-of-function (GOF) mutations underlie an inborn error of immunity hallmarked by chronic mucocutaneous candidiasis (CMC). Beyond the fungal susceptibility, attributed to Th17 failure, over half of the reported patients suffer from autoimmune manifestations, mechanism of which has not been explained yet. We hypothesized that the STAT1 mutations would affect dendritic cells' (DCs) properties and alter their inflammatory and tolerogenic functions. To test the hypothesis, we generated monocyte-derived DCs (moDCs) and tolerogenic DCs (tDCs). Functional and signaling studies, co-culture experiments and RNA sequencing demonstrated that STAT1 GOF DCs were profoundly altered in their phenotype and functions, characterized by loss of tolerogenic functions, proinflammatory skew and decreased capacity to induce Th17. Cytokine signaling, autophagy and metabolic processes were identified as the most prominently altered cellular processes. The results suggest that DCs are directly involved in STAT1 GOF-associated immune pathology, possibly contributing to both autoimmune manifestations and the failure of antifungal defense.
650    _2
$a lidé $7 D006801
650    12
$a aktivační mutace $7 D000073659
650    _2
$a autoimunita $x genetika $7 D015551
650    _2
$a mutace $7 D009154
650    _2
$a transkripční faktor STAT1 $7 D050794
650    12
$a kandidóza chronická mukokutánní $x genetika $7 D002178
650    _2
$a dendritické buňky $x metabolismus $7 D003713
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zentsova, Irena $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, Prague, Czech Republic
700    1_
$a Vrabcova, Petra $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, Prague, Czech Republic
700    1_
$a Sediva, Anna $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, Prague, Czech Republic
700    1_
$a Bloomfield, Marketa $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, Prague, Czech Republic
773    0_
$w MED00005218 $t Clinical immunology (Orlando, Fla.) $x 1521-7035 $g Roč. 246, č. - (2023), s. 109174
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36372319 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425171716 $b ABA008
999    __
$a ok $b bmc $g 1925080 $s 1190984
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 246 $c - $d 109174 $e 20221111 $i 1521-7035 $m Clinical immunology $n Clin Immunol $x MED00005218
LZP    __
$a Pubmed-20230418

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...